Acurx Pharmaceuticals, Inc. ACXP Q1 2026 earnings
Reported May 12, 2026 · Before market open
EPS-$0.62Miss by $0.03
EPS estimate-$0.59
Next report
Aug 14, 2026 (In 2 weeks)EPS estimate-$0.42
Versus estimates
Diluted EPS
Ask the moment Acurx Pharmaceuticals, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Acurx Pharmaceuticals, Inc. report Q1 2026 earnings?
- Acurx Pharmaceuticals, Inc. (ACXP) reported Q1 2026 earnings on May 12, 2026 before market open.
- What were Acurx Pharmaceuticals, Inc.'s Q1 2026 revenue and EPS?
- Acurx Pharmaceuticals, Inc. reported eps of $-0.62 for Q1 2026.
- Did Acurx Pharmaceuticals, Inc. beat estimates in Q1 2026?
- EPS missed the consensus estimate of $-0.59 by $0.03.
- How did Acurx Pharmaceuticals, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 71.8% from $-2.20.
- Where can I find Acurx Pharmaceuticals, Inc.'s Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001104659-26-058631) directly on SEC EDGAR. The filing index links above go to sec.gov.